The clinical differences were evaluated in spinal hemangioblastoma between patients with sporadic disease and patients with von Hippel-Lindau (VHL) syndrome. The distribution of hemangioblastomas in the central nervous system was investigated in 56 patients treated between 1988 and 2008 at the University of Tokyo Hospital. The characteristics of spinal hemangioblastomas were compared in 35 patients including 17 with sporadic disease and 18 with VHL syndrome treated between 1988 and 2008 at our hospital and three affiliated institutions. Spinal hemangioblastomas were much more prevalent in patients with VHL syndrome (88.2%) than in patients with sporadic disease (20.5%, p º 0.001). Spinal hemangioblastomas associated with VHL syndrome were diagnosed a decade earlier (p ＝ 0.007) and were associated with less severe neurological symptoms than sporadic lesions (p ＝ 0.004). Most patients with sporadic disease had a single lesion at the cervical or thoracic level, whereas patients with VHL syndrome had multiple lesions at all spinal levels (p ＝ 0.04). Patients with sporadic disease exhibited significant improvement in postoperative neurological status (p ＝ 0.02), whereas patients with VHL syndrome had no change in status (p ＝ 1.00). Number of removed lesions (p ＝ 0.03) and lower spinal cord lesions (p ＝ 0.05) were associated with poor surgical outcome. Tumor recurrence was correlated with partial removal of lesions (p ＝ 0.05). One third of patients with VHL syndrome developed new lesions every 2 years. The major finding of this study is that the incidence of spinal hemangioblastoma, distributed through all spinal levels, may be as high as 88% in patients with VHL syndrome, which is much greater than previously reported.
Introduction
Hemangioblastomas are benign central nervous system (CNS) neoplasms that frequently occur in the cerebellum and other areas of the CNS, including the spinal cord, spinal nerves, brainstem, ventricles, thalamus, and pituitary stalk. 4, 7, 10, 22, 24, 36) Hemangioblastomas can present as sporadic, isolated lesions or as a subset of CNS lesions in von Hippel-Lindau (VHL) syndrome. 1, 7, 24, 25, 33, 36) The clinical characteristics of patients with sporadic CNS hemangioblastomas differ from those of patients with VHL syndrome-associated lesions. Briefly, surgical outcomes are favorable in both groups, but management of CNS hemangioblastomas is more complex and prolonged for patients with VHL syndrome who tend to present with neurological symptoms and signs at a younger age and have multiple lesions and high risks of recurrence and development of new lesions. 1, 7, 9, 22, [24] [25] [26] 36) Such CNS hemangioblastomas occur predominantly as cerebellar lesions, so these findings mainly reflect the characteristics of cerebellar hemangioblastomas. In contrast, spinal lesions may have different characteristics, but no clinical study has assessed the differences, since spinal hemangioblastomas are rare in the general population and only a small number of patients (7.5-25%) with CNS hemangioblastomas harbor spinal lesions. 5, 7, 8, 14, 18, 19, 23, 24, 29, 32, [34] [35] [36] [37] [38] The present study investigated the clinical differences between patients with sporadic disease and VHL syndrome-associated spinal hemangioblastomas in a retrospective cohort based on epidemiologi- Values are number of patients (% of sporadic disease, VHL syndrome, or total). *Statistically significant difference. **Sum is greater than the total number of patients since 16 of 56 patients presented with more than one hemangioblastoma. VHL: von Hippel-Lindau. Table 2 ). Two patients with multiple CNS hemangioblastomas without lesions of VHL syndrome or family history were classified as having sporadic disease.
Surgery was indicated for symptomatic patients with corresponding lesions, and for asymptomatic patients only if the tumor and/or syrinx exhibited evidence of growth on neuroimaging. Asymptomatic lesions were removed together with symptomatic lesions in some patients with multiple lesions only if removal was possible in the same surgical field. Sixteen of 17 patients with sporadic disease underwent surgery and were diagnosed by histological examination. One patient with sporadic disease did not require surgical removal of a spinal lesion because of mild neurological symptoms and signs, and was examined by magnetic resonance (MR) imaging and angiography to exclude other spinal tumors. 2, 6, 27, 37) Two of the 16 patients required two surgeries: one had multiple symptomatic tumors and the other developed recurrence. Therefore, a total of 18 surge- ries were performed in patients with sporadic disease. Eight of 18 patients with VHL syndrome underwent surgical removal of spinal lesions and were diagnosed by histological examination. The other 10 patients underwent surgical removal of cerebellar or medullary lesions and were diagnosed by histological examination, but did not require surgical removal of spinal lesions because of no or only mild neurological deficits. Three of the 8 patients required multiple surgeries, one for multiple symptomatic tumors and two developed recurrence. Therefore, a total of 12 surgeries were performed in the patients with VHL syndrome.
Standard microsurgical resection of spinal hemangioblastomas was performed in all cases 18, 20) by the Japan Neurosurgical Society board-certified neurosurgeons with at least 20 years of surgical experience.
Medical records, radiological images, and operative records were retrospectively reviewed to compare the two groups for prevalence of spinal lesions, age at diagnosis, symptoms and signs at diagnosis, duration of symptoms, tumor number, tumor size, tumor distribution, size of syrinx, surgical outcome, tumor recurrence, and development of new lesions. Neurological status was evaluated according to the McCormick classification of clinical function in patients with intramedullary spinal cord tumor. 21) All CNS hemangioblastomas were evaluated by MR imaging with gadolinium contrast medium. Tumor size was evaluated by measuring the largest diameter of the lesion in all three coordinate planes, and then calculating the volume according to the following formula: volume ＝ width × height × length × 0.5. 18) Student's t-test, the Mann-Whitney U-test, Fisher's exact test, Wilcoxon signed-rank test, and univariate binary logistic regression analysis were used as indicated for statistical analysis of the data. SSPS II for Windows (SPSS Japan Inc., Tokyo) statistical software was used for statistical analysis. p Values Ã0.05 were considered statistically significant. Table 1 shows the locations of the CNS hemangioblastomas. Spinal hemangioblastomas were much more prevalent in patients with VHL syndrome (15 of 17 patients) than in patients with sporadic disease (8 of 39 patients, Fisher's exact test, p º 0.001). Table 2 shows the clinical presentations. Spinal hemangioblastomas in patients with VHL syndrome were diagnosed at a significantly earlier age (32.8 ± 13.8 years) than in patients with sporadic lesions (45.5 ± 12.0 years, Student's t-test, p ＝ 0.007), and neurological status at diagnosis was significantly less severe in patients with VHL syndrome than in patients with sporadic disease (Mann-Whitney Utest, p ＝ 0.004). Twelve of 18 patients with VHL syndrome were in McCormick classification I. Ten of these 12 patients were identified by routine MR surveillance imaging and exhibited no signs or symptoms. Table 2 also shows the number, size, and distribution of lesions. Multiple lesions were more frequently observed in patients with VHL syndrome (Fisher's exact test, p º 0.001). Lower cord lesions, including those in the conus medullaris and cauda equina, were more frequently observed in patients with VHL syndrome (10 of 18 patients) than in patients with sporadic disease (3 of 17 patients, Fisher's exact test, p ＝ 0.04) (Fig. 1) . Typical cases of sporadic lesions and VHL syndrome-associated lesions are shown in Fig. 2 .
Results
Surgical outcome differed between the two groups ( Fig. 3) . At the last follow-up examination after surgery (mean 70 months, 6-303 months), patients with sporadic disease exhibited significant improvement in postoperative neurological status, whereas patients with VHL syndrome had no change in status (Wilcoxon signed-rank test, p ＝ 0.02 and p ＝ Spinal Hemangioblastomas in Sporadic Disease and VHL Syndrome 1.00, respectively). Surgical induction of neurological deterioration was observed in 5 of 30 procedures. This deterioration was transient in three patients, but persisted in two patients at the last follow-up examination. Conus medullaris and cauda equina lesions caused severe postoperative lower extremity pain in three patients and persisted in two patients at last follow-up examination. A thoracic lesion related to the lateral funiculus caused transient postoperative lower extremity weakness in one patient. A cervical dorsal lesion showed adhesion between the tumor bed and dura in one patient who required additional surgery because of severe pain. Factors affecting neurological deterioration were investigated (Table 3) . Factors related to deterioration were the number of removed lesions and lower spinal lesions (binary logistic regression univariate analysis, p ＝ 0.03 and p ＝ 0.05, respectively). Age at surgery and partial removal of lesions tended to be related to deterioration (binary logistic regression analysis, p ＝ 0.07 and p ＝ 0.08, respectively).
Tumor recurrence was defined as the reappearance of tumor at the same site after complete removal or regrowth of tumor after partial removal. During the follow-up period after surgery (mean 70 months, 6-303 months), there was no significant difference in rate of tumor recurrence between patients with sporadic disease (1 of 16 patients) and patients with VHL syndrome-associated lesions (3 of 27) . Recurrence was correlated with partial removal of lesions (binary logistic regression analysis, p ＝ 0.05) (Table 4) , but not with VHL syndrome, age at surgery, tumor number, tumor size, or tumor location. Six of 18 patients with VHL syndrome exhibited development of new lesions (21 lesions) in the spinal cord during the follow-up period after surgery (54 months, 5-221 months), and three required additional surgery. One new spinal lesion developed every 25 months on average in these 6 patients with VHL syndrome. During the same period, 6 of the 18 patients exhibited development of new lesions in other regions of the CNS, and two required additional surgery.
Discussion
As predicted, patients with VHL syndrome were more likely to have multiple spinal lesions that were detected relatively early, primarily by routine surveillance imaging, and had less severe clinical presentations. Patients with sporadic lesions exhibited significant improvement following treatment, whereas patients with VHL syndrome achieved no change in status. Factors related to deterioration were the number of removed lesions and location in the lower spine. Recurrence was common in patients with only partial removal of lesions. The major finding of this study is that the distribution of hemangioblastomas in the CNS differed significantly, with a preponderance of spinal lesions in patients with VHL syndrome (88.2%, p º 0.001), which were distributed not only in the cervical and thoracic but also the lower cord regions (Tables 1  and 5 ). The prevalence of spinal hemangioblastomas has been reported in several studies. 7, 12, 15, 24, 28) Prior to the introduction of MR imaging, 24) spinal lesions were more commonly found as sporadic isolated le-Spinal Hemangioblastomas in Sporadic Disease and VHL Syndrome sions (15%) than in association with VHL syndrome (7%), whereas a more recent study 7) has shown exactly opposite findings (12% and 47%, respectively). An earlier autopsy series revealed a high incidence of spinal lesions in patients with VHL syndrome. One study found that spinal lesions were present in every 10 proven cases of VHL syndrome, 15) and another showed that multiple small miliary lesions were present in the spinal cord and nerve roots in patients with VHL syndrome. 12, 28) Our study found that spinal lesions were much more prevalent in patients with VHL syndrome (88.2%) than in those with sporadic disease (20.5%, p º 0.001). The 88% incidence of spinal hemangioblastomas in patients with VHL syndrome exceeds the highest incidence previously reported (53%), 36) possibly because we limited our analysis to patients managed in the MR imaging era. MR imaging with gadolinium contrast medium can detect even small miliary lesions noninvasively. Our findings indicate that the incidence of spinal lesions in VHL syndrome has been underestimated, and that almost all patients with VHL syndrome harbor spinal lesions.
Age at diagnosis and neurological status in patients with CNS hemangioblastomas have been reported in several studies. 4, 7, 24, 25) Age at diagnosis was significantly earlier in patients with VHL syndrome than in patients with sporadic lesions, since most patients with VHL syndrome tended to experience neurological symptoms due to cerebellar lesions at an earlier age. Prior to the MR imaging era, spinal lesions were detected after the development of neurological symptoms such as radicular pain, progressive motor weakness, posterior column sensory loss, and bleeding of spinal origin, 5, 13, 30, 31, 39) and by examinations such as myelography, angiography, and computed tomography. In our study, more than half of the patients with VHL syndrome had only mild or no neurological symptoms caused by the spinal lesions when diagnosed by MR imaging. These results indicate that the availability of high-resolution imaging has changed the demographic characteristics of patients with spinal hemangioblastomas. 33) MR imaging findings of spinal hemangioblastomas have been reported in several studies. 2, 3, 6, 17, 27) Multiple small lesions tends to indicate VHL syndrome. 2, 3) A review of sporadic isolated spinal lesions in 123 published cases found that the lesions most often occurred in the cervical and thoracic regions, and lower spinal lesions were rare. 29) A study of spinal lesions in VHL syndrome examined 44 cases with 86 lesions and found that the number of lesions was high in the cervical and thoracic areas but low at the lumbar level. 18) Our study found that lower spinal lesions, including those of the conus medullaris and cauda equina, were more frequently observed in patients with VHL syndrome (55.6%) than in patients with sporadic disease (17.6%, p ＝ 0.04). In our study, half of the lower cord lesions in VHL syndrome were detected by routine surveillance. The higher incidence of lower cord lesions in VHL syndrome can be explained by the advances in diagnostic evaluation using MR imaging, which can detect smaller asymptomatic as well as symptomatic spinal lesions. 34) These findings suggest that patients with multiple spinal lesions including the lower spinal cord are more likely to have VHL syndrome.
A major limitation of this study is that we did not perform genetic screening. In one series, a germline mutation in the VHL tumor suppressor gene was found in 3 (4.3%) of 69 patients aged 50 years or less with single hemangioblastoma, compared to none of 15 patients over 50 years of age. 11) A second limitation is that our comparison of the characteristics of spinal hemangioblastoma included patients from four different institutions. Tumor resections were performed at several centers by a number of different surgeons, although all operations were performed by the Japan Neurosurgical Society boardcertified neurosurgeons with at least 20 years of surgical experience. Therefore, we believe that this factor did not influence our findings.
The clinical characteristics differed in many respects between the two groups of patients ( Table  5 ). The distribution of tumors in the CNS differed markedly, with multiple spinal lesions distributed through all spinal levels in patients with VHL syndrome. These findings are important for the diagnosis, planning of treatment, and follow up of spinal hemangioblastoma.
